California almond industry may face challenges as ‘backup bee’ project developed as alternative to honeybee crop pollination cancelled

full e

The almond industry contributes an estimated $21 billion annually to California’s economy and it is completely dependent on honeybees for its existence. For eight years the Wonderful Company, the world’s largest almond grower, had been funding a large research project to breed another commercial pollinator—Osmia lignaria, aka the blue orchard bee, or BOB—to help the beleaguered honeybee in their vast orchards. Researchers and growers worldwide were keeping a close eye on the program’s progress. But in February 2018, right when a new generation of BOBs was to fly into the orchards, Wonderful canceled the program.

One of the key problems inhibiting their widespread use has been the inability of breeders to propagate large numbers of them.

[W]hen asked why the company decided to discontinue the program right as the BOB season was about to begin, Mark Carmel, director of corporate communications, replied in a written statement, “We’ve determined that continuation of the program is not financially feasible. In addition, we were unable to consistently achieve the level of female replication needed to make the program successful.”

Read full, original post: A Promising Backup to the Honeybee Is Shut Down

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-06-17-at-12.31.01-PM
Viewpoint: The dangerous influence of ‘woke’ post-modernism in science
Screenshot-2026-06-26-at-10.14.50-AM
Viewpoint: The facts behind the grifter-promoting wellness and anti-aging peptide craze: Don’t waste your money
ChatGPT-Image-Jun-26-2026-01_21_33-PM
How the dubious, Trump-backed, addictive drug kratom could enrich cabinet secretary Markwayne Mullin
Screenshot-2026-06-25-at-11.18.03-AM
Viewpoint: Appreciating a simpler past without swallowing the misleading ‘nature is healthier and safer’ myth
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jun-26-2026-12_10_16-PM
Europe’s heat wave fueled recycled climate-denial narratives and harassment of climate scientists
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
Screenshot-2026-06-25-at-1.48.40-PM
Glyphosate affirmed as safe: Supreme Court rejects lawsuit claiming Roundup herbicide causes cancer, upholding EPA determination
ChatGPT-Image-Jun-26-2026-11_34_33-AM
Viewpoint: RFK, Jr.’s vaccine subterfuge campaign now flies below the media radar
ChatGPT-Image-Jun-23-2026-01_12_57-PM
After Mel Gibson’s Joe Rogan comments, grifters promoting ivermectin, without evidence, as a hantavirus preventive 
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy's nutrition prescription for medical schools: Real problem, bad cure
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.